Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Canadian Haskap Berry Powder on Hypertension and Acuity in Women's Health
Sponsor: University of Manitoba
Summary
Haskap berries are rich in cyanidin-3-O-glucoside (C3G), which has been shown in vitro to enhance endothelial function. Previous clinical studies suggest haskap berry supplementation may improve cognition, mood, blood pressure, and athletic performance, but research is limited. This trial aims to contribute to the growing body of evidence on the effects of haskap berry supplementation. The trial is a 2-period, randomized, double-blinded, cross-over design lasting 16 weeks. During the first period (weeks 0-6), participants will receive either haskap berry powder or a control powder. A 4-week washout period follows (weeks 7-10), where no powder is consumed. In the second period (weeks 11-16), participants will receive the powder they did not consume in the first period.
Official title: Impact of Haskalife(TM) Canadian Haskap Berry Powder Formulation on Hypertension and Acuity in Women's Health
Key Details
Gender
FEMALE
Age Range
35 Years - Any
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2025-04-03
Completion Date
2026-08-06
Last Updated
2025-12-04
Healthy Volunteers
No
Conditions
Interventions
Haskap Berry Powder
The participants will consume four packets (16g) of haskap berry powder. The powder can be consumed with other food products.
Placebo Powder
The participants will consume four packets (24g) of placebo powder. The powder can be consumed with other food products.
Locations (1)
Richardson Centre for Food Technology and Research
Winnipeg, Manitoba, Canada